Clinical Trials
15 trialsNCT04207944 2026-06-04
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Duke University
Phase 2 Active not recruiting
NCT07213791 2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1 Recruiting
NCT07621029 2026-06-02
VENUS
Sahlgrenska University Hospital
Not yet recruiting
NCT02757859 2026-05-29
WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer
Thomas Jefferson University
Phase NA Active not recruiting
NCT04622423 2026-04-06
LiMeT
IRCCS San Raffaele
Recruiting
NCT07463872 2026-03-11
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Huazhong University of Science and Technology
Recruiting
NCT07439757 2026-02-27
AI-Powered Precision Decision-Making for Pancreatic Diseases
Changhai Hospital
Recruiting
NCT01013649 2026-02-23
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT07262957 2025-12-22
PANENCA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4 Recruiting
NCT06694792 2025-11-19
INCITE
IRCCS San Raffaele
Recruiting
NCT06519097 2025-11-13
Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT04291651 2025-09-18
UCSF PCR
University of California, San Francisco
Recruiting
NCT06574373 2025-09-03
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT02070705 2025-07-31
DCE MRI in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT07014709 2025-06-11
IPMN-GLP1RA
Hôpital Fribourgeois
Not yet recruiting